BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19904510)

  • 1. Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy.
    Engiz O; Berberoglu M; Siklar Z; Bilir P; Ocal G
    Indian J Pediatr; 2009 Sep; 76(9):950-1. PubMed ID: 19904510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
    Alves C; Silva SF
    J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
    Mieszczak J; Lowe ES; Plourde P; Eugster EA
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
    Roth C; Freiberg C; Zappel H; Albers N
    J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():945-8. PubMed ID: 12199354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole.
    Kreher NC; Pescovitz OH; Delameter P; Tiulpakov A; Hochberg Z
    J Pediatr; 2006 Sep; 149(3):416-20. PubMed ID: 16939760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
    Tessaris D; Matarazzo P; Mussa A; Tuli G; Verna F; Fiore L; Lala R
    Endocr J; 2012; 59(2):111-7. PubMed ID: 22068112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precocious pseudopuberty due to an autonomous ovarian follicular cyst: case report with a review of literatures.
    Chae HS; Rheu CH
    BMC Res Notes; 2013 Aug; 6():319. PubMed ID: 23937919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
    Eyssette-Guerreau S; Pinto G; Sultan A; Le Merrer M; Sultan C; Polak M
    J Pediatr Endocrinol Metab; 2008 Oct; 21(10):995-1002. PubMed ID: 19209621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
    Lenz AM; Shulman D; Eugster EA; Rahhal S; Fuqua JS; Pescovitz OH; Lewis KA
    Pediatrics; 2010 Sep; 126(3):e728-33. PubMed ID: 20713483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.
    Feuillan P; Calis K; Hill S; Shawker T; Robey PG; Collins MT
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2100-6. PubMed ID: 17405850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
    Papadimitriou DT; Dermitzaki E; Papagianni M; Papaioannou G; Papaevangelou V; Papadimitriou A
    J Endocrinol Invest; 2016 Apr; 39(4):439-46. PubMed ID: 26507391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
    ; Forbes JF; Cuzick J; Buzdar A; Howell A; Tobias JS; Baum M
    Lancet Oncol; 2008 Jan; 9(1):45-53. PubMed ID: 18083636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
    Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anastrozole.
    Cuzick J
    Drugs Today (Barc); 2005 Apr; 41(4):227-39. PubMed ID: 16034487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
    Jakesz R; Greil R; Gnant M; Schmid M; Kwasny W; Kubista E; Mlineritsch B; Tausch C; Stierer M; Hofbauer F; Renner K; Dadak C; Rücklinger E; Samonigg H;
    J Natl Cancer Inst; 2007 Dec; 99(24):1845-53. PubMed ID: 18073378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjuvant endocrine treatment revolution: focus on anastrozole.
    Jakesz R
    Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):301-12. PubMed ID: 16866615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
    Smollich M; Götte M; Fischgräbe J; Radke I; Kiesel L; Wülfing P
    Anticancer Res; 2009 Jun; 29(6):2167-71. PubMed ID: 19528477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is long-term adjuvant treatment of breast cancer with anastrozole indicated?
    Doggrell SA
    Expert Opin Pharmacother; 2008 Jun; 9(9):1619-22. PubMed ID: 18518790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Precocious puberty and ovarian follicular cysts].
    Wemeau-Jacquemont C
    Pediatrie; 1988; 43(4):355-60. PubMed ID: 3047663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.